Key facts
- This page summarizes Erick Wayne DeVinney's Form 4 filing for Axogen, Inc. (AXGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Dec 2021, 15:02.
Erick Wayne DeVinney - 15 Dec 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)
- Reporting relationship
- VP Peripheral Nerve Science
- Issuer ticker
- AXGN
- Reported as of
- 15 Dec 2021
- Net transaction value
- -$4.8
- SEC form
- 4
- Accepted by SEC
- 17 Dec 2021, 15:02:34 UTC
- Prior SEC filing
- 21 Jul 2021
- Next SEC filing
- 22 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/Erick DeVinney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Erick Wayne DeVinney filed Form 4 for Axogen, Inc. (AXGN) on 17 Dec 2021.
Change
- Previous filing in this sequence was filed on 21 Jul 2021.
- Current net transaction value: -$4.8.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXGN
transaction
Common Stock
Options Exercise
- Transaction value
- $36,700
- Shares
- +10,000
- Change %
- +12%
- Price
- $3.67
- Shares after
- 90,426
- Date
- 15 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
AXGN
transaction
Common Stock
Tax liability
- Transaction value
- $36,705
- Shares
- -4,171
- Change %
- -4.6%
- Price
- $8.80
- Shares after
- 86,255
- Date
- 15 Dec 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXGN
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.67
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This reflects the number of shares that became vested as of December 29, 2018.
Footnote F2
Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3.